加拿大联邦政府最近批准的一种用于绝经妇女名叫Evista的代雌激素,目前已面市。 这种新药的成份是raloxifere,每天只须服用1片就可代替激素疗法,预防绝经妇女骨质疏松的发生。 绝经妇女因卵巢停止分泌雌性激素,易导致骨质疏松症。加拿大目前约有100万名妇女患此症,以往医生 The estrogen recently approved by the federal government of Canada for Evista, a menopausal woman, is now available. The new drug is raloxifere, taking only one tablet daily instead of hormone therapy to prevent osteoporosis in postmenopausal women. Menopause women stop ovarian estrogen secretion, easily lead to osteoporosis. There are about 1 million women in Canada suffering from this disease in the past